Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(10):e47470.
doi: 10.1371/journal.pone.0047470. Epub 2012 Oct 17.

Discrete choice experiment to evaluate factors that influence preferences for antibiotic prophylaxis in pediatric oncology

Affiliations

Discrete choice experiment to evaluate factors that influence preferences for antibiotic prophylaxis in pediatric oncology

Dean A Regier et al. PLoS One. 2012.

Abstract

Background: Bacterial and fungal infections in pediatric oncology patients cause morbidity and mortality. The clinical utility of antimicrobial prophylaxis in children is uncertain and the personal utility of these agents is disputed. Objectives were to use a discrete choice experiment to: (1) describe the importance of attributes to parents and healthcare providers when deciding between use and non-use of antibacterial and antifungal prophylaxis; and (2) estimate willingness-to-pay for prophylactic strategies.

Methods: Attributes were chances of infection, death and side effects, route of administration and cost of pharmacotherapy. Respondents were randomized to a discrete choice experiment outlining hypothetical treatment options to prevent antibacterial or antifungal infections. Each respondent was presented 16 choice tasks and was asked to choose between two unlabeled treatment options and an opt-out alternative (no prophylaxis).

Results: 102 parents and 60 healthcare providers participated. For the antibacterial discrete choice experiment, frequency of administration was significantly associated with utility for parents but not for healthcare providers. Increasing chances of infection, death, side effects and cost were all significantly associated with decreased utility for parents and healthcare providers in both the antibacterial and antifungal discrete choice experiment. Parental willingness-to-pay was higher than healthcare providers for both strategies.

Conclusion: Chances of infection, death, side effects and costs were all significantly associated with utility. Parents have higher willingness-to-pay for these strategies compared with healthcare providers. This knowledge can help to develop prophylaxis programs.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow diagram of parent participants through the study.
Figure 2
Figure 2. Attribute importance ranking for antibacterial prophylaxis.
Abbreviation: HCPs – healthcare providers.
Figure 3
Figure 3. Attribute importance ranking for antifungal prophylaxis.

References

    1. Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J (2007) Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood 110: 3532–3539. - PubMed
    1. Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106: 2258–2266. - PubMed
    1. Gafter-Gvili A, Fraser A, Paul M, Leibovici L (2005) Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 142: 979–995. - PubMed
    1. Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, et al. (2007) Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol 25(34): 5471–5489. - PubMed
    1. Lehrnbecher L, Ethier MC, Zaoutis T, Creutzig U, Gamis A, et al. (2009) International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia. Br J Haematol 147: 125–128. - PubMed

Publication types